Post-earnings recap
Reported
Thu, May 1, 2025
EPS actual
$-2.52
EPS est.
$-2.92
EPS surprise
+13.70%
1-day move
-5.29%
Moderna's earnings report shows a significant loss per share, which was better than some expectations but still reflects ongoing challenges. The stock fell by over 5% in reaction, indicating investor concern about the company's current trajectory and lack of revenue updates. Without guidance, uncertainty remains about future performance and market positioning.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-2.52 | N/A | +13.70% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about ongoing market conditions and the impact on future performance. They reiterated their commitment to innovation and research.
Management acknowledged the challenges faced in the current market environment.
They emphasized a focus on long-term strategies despite short-term setbacks.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—